Development

A rapamycin-analog serum trial reports improved firmness

development2026-10-12biotechreported-trial

Claim

The newsletter reports a skin-serum trial claiming 21% firmer skin using a rapamycin analog.

Reported metric: 21% firmer skin

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Indexed from Dr. Alex Wissner-Gross’s October 12, 2026 edition. This is an attributed summary; linked-source claims have not been independently verified.

Knowledge graphopen in browser →

Reported in
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.